ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.20
      0.91%
      US Tech 100
      17,168.00
      1.82%
      Dow Jones
      38,225.66
      0.85%
      Brent Oil
      83.63
      0.11%
      Bitcoin
      59,252.47
      1.74%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Biora Therapeutics Inc (BIOR)

      7. Biora Therapeutics Inc (BIOR) News

      BIOR Biora Therapeutics Inc

      0.716
      0.074 (11.53%)
      After Hours
      Last Updated: 18:42:58
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Biora Therapeutics Inc BIOR NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.074 11.53% 0.716 18:42:58
      Open Price Low Price High Price Close Price Prev Close
      0.642 0.631 0.72 0.7128 0.642
      more quote information »

      Recent News

      Date Time Source Heading
      5/02/202410:07IHNWFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      4/30/202408:00GLOBEBiora Therapeutics Announces Completion of..
      4/08/202408:00GLOBEBiora Therapeutics Announces New Patent Covering its BioJet™..
      4/04/202408:00GLOBEBiora Therapeutics Achieves Positive Interim Results for..
      4/03/202416:05GLOBEBiora Therapeutics Announces Closing of $6 Million..
      4/01/202408:00GLOBEBiora Therapeutics Announces $6 Million Registered Direct..
      3/26/202416:05GLOBEBiora Therapeutics Provides Corporate Update and Reports..
      3/26/202407:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
      3/18/202408:00GLOBEBiora Therapeutics to Report Fourth Quarter and Full Year..
      3/11/202408:11EDGAR2Form 8-K - Current report
      3/11/202408:00GLOBEBiora Therapeutics Further Reduces Net Debt and Monetizes..
      2/26/202408:00GLOBEBiora Therapeutics Announces Successful Completion of..
      2/15/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/14/202414:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/08/202408:00GLOBEBiora Therapeutics Announces Participation in Canaccord..
      1/22/202408:00GLOBEBiora Therapeutics Announces Participation in Fireside Chat..
      1/16/202417:20EDGAR2Form 8-K - Current report
      1/16/202408:00GLOBEBiora Therapeutics Provides Outlook for 2024
      1/08/202408:00GLOBEBiora Therapeutics Announces Initiation of Phase 1 Clinical..
      1/02/202408:00GLOBEBiora Therapeutics Progresses Research Collaboration for the..
      1/02/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      12/22/202317:19EDGAR2Form S-3 - Registration statement under Securities Act of..
      12/20/202316:35EDGAR2Form SC 13D/A - General statement of acquisition of..
      12/19/202308:00GLOBEBiora Therapeutics Announces New Patent for its NaviCap™..
      12/18/202308:06EDGAR2Form 8-K - Current report
      12/18/202308:00GLOBEBiora Therapeutics Accelerates Debt Reduction and Raises..
      12/15/202317:25EDGAR2Form 8-K - Current report
      12/11/202308:00GLOBEBiora Therapeutics Announces New Research Collaboration for..
      12/01/202306:06EDGAR2Form 8-K - Current report
      11/30/202318:53DJNBiora Therapeutics Shares Rise 64% After FDA Clears..
      11/30/202317:29DJNBiora Therapeutics Application for Ulcerative Colitis..
      11/30/202316:48GLOBEBiora Therapeutics Announces FDA Clearance of IND..
      11/13/202316:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202316:05GLOBEBiora Therapeutics Provides Corporate Update and Reports ..
      11/06/202308:00GLOBEBiora Therapeutics to Report Third Quarter 2023 Financial..
      10/30/202316:05GLOBEBiora Therapeutics Submits Updated IND Application for..
      10/23/202317:30GLOBEBiora Therapeutics to Submit Updated IND Application for..
      10/13/202306:04EDGAR2Form 8-K - Current report
      10/11/202306:01EDGAR2Form 8-K - Current report
      10/06/202317:19EDGAR2Form 8-K - Current report
      10/05/202308:00GLOBEBiora Therapeutics Presents Data on the BioJet™ Systemic..
      9/25/202308:00GLOBEBiora Therapeutics Announces Submission of IND Application..
      9/19/202316:15EDGAR2Form SC 13D/A - General statement of acquisition of..
      9/19/202308:06EDGAR2Form 8-K - Current report
      9/19/202308:00GLOBEBiora Therapeutics Reduces Debt and Largest Shareholder..
      9/11/202308:01GLOBEBiora Therapeutics to Present at H.C. Wainwright 25th Annual..
      9/05/202308:00GLOBEBiora Therapeutics Progresses its BioJet™ Systemic Oral..
      8/17/202316:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/17/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/14/202316:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      Your Recent History

      NASDAQ
      BIOR
      Biora Therapeutics
      Delayed Upgrade Clock